Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the international registry of hepatic tumors in liver transplantation

Liver Transplantation

Volumn 13, Issue 3, 2007, Pages 391-399

  Onaca, Nicholas ^a   Davis, Gary L ^a   Goldstein, Robert M ^a   Jennings, Linda W ^a   Klintmalm, Göran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CADAVER DONOR; CANCER PATIENT; CANCER REGISTRY; CANCER SIZE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT INDICATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 33947388455     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21095     Document Type: Article

References (45)

1. El Serag HB, Mason AC. Rising Incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999:340: 745-750.
2. Davis, GL, Albright JE, Cook SF. Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver transpl 2003;9:331-338.
3. El-Serag HB. Davila JA, Petersen NJ, McGlynn KA. The continuing increase to the incidence of hepatecelular carcinoma in the United States: an update. An Intern Med 2003:139:817-823.
4. Nart D. Arikan C, Akyildiz M, Yuce G. Demirpolat G, Zaytunlu M, et al. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis. Transplant Proc 2003:35:2986-2990.
5. Mazzaferro V. Regalia E. Doci R, Andreola S, Pulverinte A. Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
6. Sharma, P, Balan V, Hernandez JL, Harper AM Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD Impact, Liver Transplantation 2004; 10:36-41.
7. Ringe D, Pichlmayr R, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15:270-285.
8. Marsh JW. Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003;9:693-696.
9. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma. (HCC) in adults Gut 2003; 52(Suppl 3): 1-8.
10. Fung J, Marsh W. The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl 2002;8:775-777.
11. Llovet JM, Bruix, J, Gores GJ. Surgical resection versus trasplantation for early hepatocellular carcinoma: clues for the best strategy, Hepatology 200:31:1019-1021.
12. Neuhaus. P, Jona S, Bechstein WO, Wex, C, Kling N, Settmacher U, al-Abadi H. Liver transplantation for hepatocellular carcinoma. Transplant Proc 1999:31:469-471.
13. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991:110;726-734.
14. Iwatsuki S. Starzl TE, Sheahan DG. Yokoyama I, Demetris AJ, Todo S. et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991:214;221-228.
15. Roayale S, Scwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004;10:534-540.
16. Bismuth H. Chiche, L. Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocelludar carcinoma in cirrhotic patients. Ann Sung 1993;218:145-151.
17. Figueras J, Jaurrieta E, Valls C, Benasco C. Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997:25:1485-1489.
18. Sauer P, Kraus TW, Schemmer P. Mehrabi A. Stremmel W, Buechler MW, Encke J. Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria. Transplantation 2005;80:S105-S1O8.
19. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of doe impact of tumor charactertstics on outcome. Ann Surg 1998;228:479-490.
20. Yao FY, Ferrell L, Bass NM, Watson JJ. Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
21. Yao FY, Ferrell L, Bass NM, Bacchetti P. Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburg modified TNM criteria. Liver Transpl 2002;8:765-774.
22. Lee KW, Park JW, Joh JW, Kim SJ, Chol SH, Heo JS. et al. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation. Transplant Proc 2004;36:2289-2290.
23. Santoyo J, Suarez MA, Fernandez-Aguilar JL, Jimenez M, Perez Daga JA, Sanchez-Perez B, et al. Liver transplant results for hepatocellular carcinoma applying strict pre-operative selection criteria. Transplant Proc 2005;37: 1488-1490.
24. Merli M. Nicolini G, Gentili F, Novelli G. Iappelli M, Cascairo G, et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 2005;37:2535-2540.
25. Zavaglia C. De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005:100:2708-2716.
26. Shetty K. Timmins K. Brensinger C, Furth EE. Rattan S. Sun W, et al. Liver transplantation for hepatacellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004:10:911-918.
27. Mazzaferro V, Rondinara GF, Rossi G. Regalia E, De Carlis L, Caccamo L, et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc 1994:26:3557-3560.
28. Ringe B, Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted? Hepatology 1997; 26:507-508.
29. Cillo U, Vitale A, Bassanello M, Boccagni P. Brolese A. Zanus G, et al. Liver, transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma Ann Surg 2004:239:150-159.
30. Durand F, Belghiti J. Liver transplantation for hepatocellular carcinoma: should we push the limits? Liver Transpl 2003;9:697-699.
31. Makuuchi M, Sano K. The surgical apppproach HCC: our progress and results in Japan. Liver Transpl 2004:1(2 Suppl 1):S646-S52.
32. Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein TM, et al. Adult living donor liver transplantation far patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004;239: 142-149.
33. Gondolesi G, Munoz L, Matsumoto C, Fishbein T, Sheiner P, Emre S, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002;6:102-107.
34. Schwartz M. Liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2004:10(2 Suppl 1): S81-S85.
35. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, Prieto J. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001;7:631-636.
36. Llovet JM, Fuster J, Bruix J, Barcelona-Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004;10(2 Suppl 1):S115-S120.
37. Yao FY, Roberts JP. Applying expanded criteria to liver transplantation for hepacellular carcinoma: too much too soon or is now, the time? Liver Transpl 2004:10:919-921.
38. Burrel M. Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003;38:1034-1042.
39. Kim RD, Nazarey P, Katz E, Chari RS. Laparoscopic staging and tumor ablation for hepatorellular carcinoma in child C cirrhoties evaluated for orthotopic liver transplantation. Surg Endosc 2004;18:39-44.
40. Rode A. Bancel B. Douek P, Chevillier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327-336.
41. Steingruber IE, Mallouhi A, Czermak BV, Waldenberger P, Gassaner E, Offner F, et al. Pretransplantation evaluation of the cirrhotic liver with explantation correlation: acccuracy of CT arterioportography and digital subtraction hepatic angiography in revealing hepalocellular carcinoma Am J Roentgenol 2003;181:99-108.
42. Stoker J, Romijn MG, de Man RA. Brouwer JT, Weverling GJ, van Muiswinkel JM, et al. Prospective comparative study of spiral computer tomography and Magnetic resonance imaging for detection of hepatocellular carcinoma. Gut 2002;51:105-107.
43. Tan CK, Gores GJ, Steers JL, Porayko MK, Hay JE, Rakela J, et al. Orthotopic liver transplantation for preoperative early-stage hepatocellufar carcinoma. Mayo Clin Proc 1994:69:509-514.
44. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG. Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US and PET. Radiology 2003; 226:533-542.
45. Bruix, J, Fuster J, Llovet JM. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700-702.